Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Clinical trial NCT03023046 · COMPLETED
Trial details
- NCT number
- NCT03023046
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-23
- Primary completion
- 2021-05-20
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.